Skip to main content

Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction.

Publication ,  Journal Article
McCord, J; Newby, LK; deFilippi, CR
Published in: Circulation
July 17, 2018

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 17, 2018

Volume

138

Issue

3

Start / End Page

316 / 318

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Troponin T
  • Sensitivity and Specificity
  • Observer Variation
  • Myocardium
  • Myocardial Infarction
  • Humans
  • High-Throughput Screening Assays
  • Emergency Medical Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
McCord, James, L Kristin Newby, and Christopher R. deFilippi. “Designing a Better Mousetrap: Reflections on the November 28, 2017, US Food and Drug Administration Meeting on Next-Generation "High-Sensitivity" Cardiac Troponin Assays to Diagnose Myocardial Infarction.Circulation 138, no. 3 (July 17, 2018): 316–18. https://doi.org/10.1161/CIRCULATIONAHA.118.033955.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 17, 2018

Volume

138

Issue

3

Start / End Page

316 / 318

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States
  • Troponin T
  • Sensitivity and Specificity
  • Observer Variation
  • Myocardium
  • Myocardial Infarction
  • Humans
  • High-Throughput Screening Assays
  • Emergency Medical Services